title: Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke.
abstract: Diabetes is a major risk factor of stroke and is associated with increased frequency of stroke and a poorer prognosis for recovery. In earlier studies we have utilized type 2 diabetic mouse models of stroke and demonstrated that diabetic db/db and ob/ob mice experience larger infarct volumes and impaired recovery associated with greater infiltration of macrophage following hypoxic-ischemic (H/I) insult than their heterozygous non-diabetic db/+ and ob/+ littermates. To obtain a better understanding of the pathogenesis of the impaired recovery, we have investigated the role of matrix metalloproteases and their endogenous inhibitors in the breakdown of the blood-brain barrier (BBB) following H/I. Diabetic db/db mice showed a significant and more rapid increase in matrix metalloprotease (MMP)-9 mRNA, protein and gelatinolytic activity compared with db/+, which resulted in an increased degradation of occludin and collagen IV and subsequently, an increased BBB permeability and greater infiltration of neutrophils into the infarct area. The expression of the MMPs, especially in the db/+ mice, is preceded by an elevated expression of their endogenous tissue inhibitors of metalloproteases (TIMPs) 1, 2, and 3, whereas in the db/db mice, a lower expression of the TIMPs is associated with greater MMP 3 and 9 expression. These results suggest that an imbalance in the MMPs/TIMPs cascade in the diabetic mouse, particularly MMP-9, results in a greater neutrophil invasion, a compromised BBB and consequently a greater insult.
authors.affiliation: Department of Neural and Behavioral Sciences, College of Medicine, Penn State University, Hershey Medical Center, Hershey, Pennsylvania, USA. ruk10@psu.edu
authors.forename: Rashmi
authors.initials: R
authors.lastname: Kumari
authors.forename: Lisa B
authors.initials: LB
authors.lastname: Willing
authors.forename: Shyama D
authors.initials: SD
authors.lastname: Patel
authors.forename: Karen A
authors.initials: KA
authors.lastname: Baskerville
authors.forename: Ian A
authors.initials: IA
authors.lastname: Simpson
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000201:enzymology* / Q000503:physiopathology; D048909:Diabetes Complications / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D004195:Disease Models, Animal; D020925:Hypoxia-Ischemia, Brain / Q000201:enzymology* / Q000209:etiology / Q000235:genetics; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism* / Q000502:physiology; D051379:Mice; D008817:Mice, Mutant Strains; D008820:Mice, Obese; D020127:Recovery of Function / Q000235:genetics*; D020521:Stroke / Q000201:enzymology* / Q000209:etiology / Q000235:genetics; D015854:Up-Regulation / Q000235:genetics
chemical_list: D020780:Matrix Metalloproteinase 9; C501830:Mmp9 protein, mouse